摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(1S)-6,7-dimethoxy-2-methyl-1-[2-(3,4,5-trimethoxyphenyl)ethyl]-1,2,3,4-tetrahydroisoquinoline | 22324-11-4

中文名称
——
中文别名
——
英文名称
(1S)-6,7-dimethoxy-2-methyl-1-[2-(3,4,5-trimethoxyphenyl)ethyl]-1,2,3,4-tetrahydroisoquinoline
英文别名
(S)-6,7-dimethoxy-1-(3,4,5-trimethoxyphenethyl)-N-methyl-1,2,3,4-tetrahydroisoquinoline;2-methyl-1,2,3,4-tetrahydro-6,7-dimethoxy-1-(S)-(3,4,5-trimethoxyphenethyl)isoquinoline;(S)-5'-methoxyhomolaudenosine;(+)-O,O-dimethylautumnaline;(1S)-6,7-dimethoxy-2-methyl-1-[2-(3,4,5-trimethoxyphenyl)ethyl]-3,4-dihydro-1H-isoquinoline
(1S)-6,7-dimethoxy-2-methyl-1-[2-(3,4,5-trimethoxyphenyl)ethyl]-1,2,3,4-tetrahydroisoquinoline化学式
CAS
22324-11-4
化学式
C23H31NO5
mdl
——
分子量
401.503
InChiKey
YCGCUOAWNILUJC-SFHVURJKSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    505.2±50.0 °C(Predicted)
  • 密度:
    1.098±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    4
  • 重原子数:
    29
  • 可旋转键数:
    8
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.48
  • 拓扑面积:
    49.4
  • 氢给体数:
    0
  • 氢受体数:
    6

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    (1S)-6,7-dimethoxy-2-methyl-1-[2-(3,4,5-trimethoxyphenyl)ethyl]-1,2,3,4-tetrahydroisoquinolinechromium(III) oxide 三氟化硼乙醚三氟乙酸三氟乙酸酐 作用下, 以 二氯甲烷 为溶剂, 反应 48.0h, 以28%的产率得到(6aS)-1,2,10,11,12-pentamethoxy-6-methyl-4,5,6,6a,7,8-hexahydrobenzo[6,7]cyclohepta[1,2,3-ij]isoquinoline
    参考文献:
    名称:
    手性钌配合物催化不对称转移加氢合成一些四环异喹啉生物碱
    摘要:
    手性钌配合物催化的不对称转移氢化反应是对映体选择性合成( R )-(+)-可乐树碱,( S )-(-)-高原型小ber碱和( S )-(+)-高磷吗啡碱的对映体纯度。
    DOI:
    10.1007/s00706-005-0341-8
  • 作为产物:
    描述:
    methyl <(2S,3R)-dihydroxy-3-(6',7'-dimethoxy-1',2',3',4'-tetrahydroisoquinolin-1'(R)-yl)>propanoate hydrochloride 在 platinum(IV) oxide 吡啶甲醇sodium periodate 、 lithium aluminium tetrahydride 、 正丁基锂氢气sodium methylate 作用下, 以 四氢呋喃甲醇 为溶剂, -30.0~25.0 ℃ 、101.33 kPa 条件下, 反应 12.25h, 生成 (1S)-6,7-dimethoxy-2-methyl-1-[2-(3,4,5-trimethoxyphenyl)ethyl]-1,2,3,4-tetrahydroisoquinoline
    参考文献:
    名称:
    异喹啉生物碱的对映选择性合成:苯乙基异喹啉和阿朴啡生物碱
    摘要:
    从 D-(-)-酒石酸开始,开发了一种新的改进方法,用于制备 (R)-2-alkoxycarbonyl-1-formyl-1,2,3,4-四氢-6,7-二甲氧基异喹啉。这些醛在高对映体纯度的异喹啉生物碱的不对称合成中的用途已扩展到苯乙基异喹啉的合成,后者已通过直接步骤进一步转化为高原小檗碱和高卟啉环系统。以这种方式,已经合成了 (S)-高莫拉丹苷、(S)-5'-甲氧基高莫拉丹苷、(S)-2,3,9,10,11-五甲氧基高原小檗碱和 (S)-O-methylkreysigine。(S)-laudanosine 转化为 (S)-glaucine,一种阿朴啡生物碱,也已实现。
    DOI:
    10.1139/v87-393
点击查看最新优质反应信息

文献信息

  • The Synthesis of Isoquinoline Alkaloid and Its Related Compounds Using Alanine Derivatives as Chiral Auxiliaries
    作者:Takashi Itoh、Kazuhiro Nagata、Masashi Yokoya、Michiko Miyazaki、Keiko Kameoka、Shigeru Nakamura、Akio Ohsawa
    DOI:10.1248/cpb.51.951
    日期:——
    Chiral 1-substituted isoquinoline derivatives, which were obtained by the reaction using alanine derivatives as chiral auxiliaries, were transformed to (S)-2,3,9,10,11-pentamethoxyhomoprotoberberine (7) and a synthetic intermediate for O-methylkreysigine (9) in good yields and high stereoselectivity. The corresponding chiral allyl derivative of isoquinoline was transformed to a pyrrolidinoisoquinoline
    通过使用丙氨酸衍生物作为手性助剂的反应获得的手性1-取代的异喹啉衍生物被转化为(S)-2,3,9,10,11-五甲氧基高原型小ine碱(7)和O-甲基克雷西金的合成中间体( 9)产率高且立体选择性高。异喹啉的相应手性烯丙基衍生物以高度对映选择性的方式转化为吡咯烷基异喹啉(16)。
  • Biomimetic Total Synthesis of <i>Dysoxylum</i> Alkaloids
    作者:Carlos E. Puerto Galvis、Vladimir V. Kouznetsov
    DOI:10.1021/acs.joc.9b02093
    日期:2019.12.6
    A five-step total synthesis of Dysoxylum alkaloids has been achieved using a biomimetic approach from zanthoxylamide protoalkaloids. The synthesis featured a direct amidation and a Bischler-Napieralski reaction to form the dihydroisoquinoline ring, which was then subjected to a Noyori asymmetric transfer hydrogenation to establish the stereogenic center at C-1. Our synthetic sequence provides an important
    使用仿生方法,由花椒苷酰胺原生物碱实现了Dysoxylum生物碱的五步全合成。该合成具有直接酰胺化和Bischler-Napieralski反应形成二氢异喹啉环的特征,然后将其进行Noyori不对称转移氢化,以在C-1处建立立体异构中心。我们的合成序列为Dysoxylum生物碱的生物合成起源提供了重要的视角,因为获得了6种天然生物碱和12种合成类似物,具有很高的对映选择性,总收率高达68%。此外,我们描述了Dysoxylum生物碱对斑马鱼胚胎的急性毒性,将它们的毒性与相应的zanthoxylamide原生物碱的毒性进行了比较,并建立了对映选择性-毒性关系。
  • Nagata, Kazuhiro; Itoh, Takashi; Kameoka, Keiko, Heterocycles, 2001, vol. 55, # 12, p. 2269 - 2272
    作者:Nagata, Kazuhiro、Itoh, Takashi、Kameoka, Keiko、Miyazaki, Michiko、Ohsawa, Akio
    DOI:——
    日期:——
  • CZARNOCKI, ZBIGNIEW;MACLEAN, DAVID B.;SZAREK, WALTER A., CAN. J. CHEM., 65,(1987) N 10, 2356-2361
    作者:CZARNOCKI, ZBIGNIEW、MACLEAN, DAVID B.、SZAREK, WALTER A.
    DOI:——
    日期:——
  • Enantioselective synthesis of isoquinoline alkaloids: phenylethylisoquinoline and aporphine alkaloids
    作者:Zbigniew Czarnocki、David B. MacLean、Walter A. Szarek
    DOI:10.1139/v87-393
    日期:1987.10.1
    A new and improved procedure for the preparation of (R)-2-alkoxycarbonyl-1-formyl-1,2,3,4-tetrahydro-6,7-dimethoxyisoquinolines has been developed beginning from D-(−)-tartaric acid. The utility of these aldehydes in the asymmetric synthesis of isoquinoline alkaloids of high enantiomeric purity has been extended to the synthesis of phenylethylisoquinolines, which have been further transformed in straightforward
    从 D-(-)-酒石酸开始,开发了一种新的改进方法,用于制备 (R)-2-alkoxycarbonyl-1-formyl-1,2,3,4-四氢-6,7-二甲氧基异喹啉。这些醛在高对映体纯度的异喹啉生物碱的不对称合成中的用途已扩展到苯乙基异喹啉的合成,后者已通过直接步骤进一步转化为高原小檗碱和高卟啉环系统。以这种方式,已经合成了 (S)-高莫拉丹苷、(S)-5'-甲氧基高莫拉丹苷、(S)-2,3,9,10,11-五甲氧基高原小檗碱和 (S)-O-methylkreysigine。(S)-laudanosine 转化为 (S)-glaucine,一种阿朴啡生物碱,也已实现。
查看更多

同类化合物

1-<2-(4-羟基-3-甲氧基)乙基>-7-羟基-6-甲氧基-1,2,3,4-四氢异喹啉 (1R)-1-(4-methoxyphenyl)-2-<(1R)-1,2,3,4-tetrahydro-6,7-dimethoxy-2-methyl-1-isoquinolyl>ethanol (1R)-1-(4-methoxyphenyl)-2-<(1S)-1,2,3,4-tetrahydro-6,7-dimethoxy-2-methyl-1-isoquinolyl>ethanol (1S)-1-(4-methoxyphenyl)-2-<(1S)-1,2,3,4-tetrahydro-6,7-dimethoxy-2-methyl-1-isoquinolyl>ethanol (1S)-1-(4-methoxyphenyl)-2-<(1R)-1,2,3,4-tetrahydro-6,7-dimethoxy-2-methyl-1-isoquinolyl>ethanol Isoautumnaline 6-benzyloxy-1-(3-benzyloxy-4,5-dimethoxyphenethyl)-7-methoxy-2-methyl-1,2,3,4-tetrahydroisoquinoline 7-Benzyloxy-6-methoxy-2-methyl-1-(4-methoxy-phenethyl)-1,2,3,4-tetrahydro-isochinolin 1-(4-methoxyphenethyl)-1,2,3,4-tetrahydro-6-methoxy-2-methyl-7-isoquinolinol (+)-colchiethine 7-hydroxy-6-methoxy-1-(3',4',5'-trimethoxyphenethyl)-N-methyl-1,2,3,4-tetrahydroisoquinoline (+)-colchiethanamine (+/-)-N,N-Dimethyl-6,7,3',4'-tetramethoxyphenylethyl-1,2,3,4-tetrahydroisoquinolinium iodide [(1S)-7-methoxy-1-[2-(4-methoxyphenyl)ethyl]-2-methyl-3,4-dihydro-1H-isoquinolin-6-yl] 2,2-dimethylpropanoate [4-[2-[(1S)-6-(2,2-dimethylpropanoyloxy)-7-methoxy-2-methyl-3,4-dihydro-1H-isoquinolin-1-yl]ethyl]phenyl] 2,2-dimethylpropanoate (1S)-6,7-dimethoxy-2-methyl-1-[2-(3,4,5-trimethoxyphenyl)ethyl]-1,2,3,4-tetrahydroisoquinoline (S)-autumnaline 6,7-dimethoxy-1-(4-methoxyphenylethyl)-2-methyl-1,2,3,4-tetrahydroisoquinoline 1,2,3,4-tetrahydro-6-hydroxy-7-methoxy-1-(2-(3',4'-dimethoxyphenyl)ethyl)-2-methylisoquinoline (S)-(+)-homolaudanosine (-)-Homolaudanosine (1R)-1-[2-(4-hydroxyphenyl)ethyl]-6-methoxy-2-methyl-3,4-dihydro-1H-isoquinolin-7-ol (1S)-1-[2-(4-hydroxy-3-methoxyphenyl)ethyl]-6-methoxy-2-methyl-1,2,3,4-tetrahydroisoquinolin-2-ium-7-ol (1S)-1-[2-(4-hydroxyphenyl)ethyl]-6-methoxy-2-methyl-1,2,3,4-tetrahydroisoquinolin-2-ium-7-ol (1R)-1-[2-(4-hydroxy-3-methoxyphenyl)ethyl]-6-methoxy-2-methyl-3,4-dihydro-1H-isoquinolin-7-ol (1S)-1-[2-(4-hydroxy-3-methoxyphenyl)ethyl]-6-methoxy-2-methyl-3,4-dihydro-1H-isoquinolin-7-ol (S)-1-[2-(4-Hydroxy-phenyl)-ethyl]-6-methoxy-2-methyl-1,2,3,4-tetrahydro-isoquinolin-7-ol (1R)-1-[2-(4-hydroxy-3-methoxyphenyl)ethyl]-6-methoxy-2-methyl-1,2,3,4-tetrahydroisoquinolin-2-ium-7-ol (1R)-1-[2-(4-hydroxyphenyl)ethyl]-6-methoxy-2-methyl-1,2,3,4-tetrahydroisoquinolin-2-ium-7-ol (1S)-1-[2-(4-hydroxy-3,5-dimethoxyphenyl)ethyl]-6-methoxy-2-methyl-3,4-dihydro-1H-isoquinolin-7-ol N-Methyl-1-(3,5-dimethoxy-4-hydroxy-phenethyl)-2-methyl-7-hydroxy-6-methoxy-1,2,3,4-tetrahydro-isochinolin (1R)-1-[2-(4-hydroxy-3,5-dimethoxyphenyl)ethyl]-6-methoxy-2-methyl-3,4-dihydro-1H-isoquinolin-7-ol (1S)-1-[2-[4-[[(1R)-1-[2-(4-hydroxyphenyl)ethyl]-6-methoxy-2-methyl-3,4-dihydro-1H-isoquinolin-7-yl]oxy]phenyl]ethyl]-6-methoxy-2-methyl-3,4-dihydro-1H-isoquinolin-7-ol 1-{2-[4-({1-[2-(4-Hydroxyphenyl)ethyl]-6-methoxy-2-methyl-1,2,3,4-tetrahydroisoquinolin-7-yl}oxy)phenyl]ethyl}-6-methoxy-2-methyl-1,2,3,4-tetrahydroisoquinolin-7-ol 1-[2-(4-hydroxyphenyl)ethyl]-7-methoxy-2-methyl-3,4-dihydro-1H-isoquinolin-6-ol 7-Hydroxy-1-(3-hydroxy-4,5-dimethoxy-phenethyl)-6-methoxy-2-methyl-1,2,3,4-tetrahydro-isochinolin 7-Hydroxy-1-(4-hydroxy-phenethyl)-6-methoxy-2-methyl-1,2,3,4-tetrahydro-isochinolin, 1-<2-(p-Hydroxy-phenyl)-ethyl>-2-methyl-6-methoxy-7-hydroxy-1,2,3,4-tetrahydro-isochinolin (+/-)-isoautumnaline homolaudanosine 7-methoxy-1-(4-methoxyphenylethyl)-2-methyl-1,2,3,4-tetrahydroisoquinolin-6-ol